Peritoneal dialysis in patients with primary cardiac failure complicated by renal failure

Research output: Contribution to journalArticleAcademicpeer-review

24 Citations (Scopus)

Abstract

Background/Aims: Clinical outcome in cardiorenal syndrome type II and treated with peritoneal dialysis (PD). Methods: Retrospective analysis over a period of 10 years. Results: Twenty-four patients with mean age at start of dialysis of 67 +/- 10 years had mean survival on dialysis of 1.03 +/- 0.84 years (median survival 1.0 year). The number of hospitalizations for cardiovascular causes were reduced (13.7 +/- 26.5 predialysis vs. 3.5 +/- 8.8 days/patient/month postdialysis, p = 0.001). Patients who survived longer than the median survival time (n = 12) also had a reduced number of hospitalizations for all causes (3.7 +/- 3.8 predialysis vs. 1.4 +/- 2.1 days/patient/month postdialysis, p = 0.041), a lower age (62 +/- 10 vs. 71 +/- 8 years, p = 0.013) and fewer had diabetes (2 vs. 7 patients, p = 0.039), but left ventricular ejection fraction was not different. Conclusion: After starting PD for cardiorenal syndrome, hospitalizations for cardiovascular causes were reduced for all patients. Survival after starting PD is highly variable. Age and diabetes seem to be significant prognostic factors, but not left ventricular ejection fraction.
Original languageEnglish
Pages (from-to)146-52
JournalBlood Purification
Volume30
Issue number2
DOIs
Publication statusPublished - 1 Jan 2010

Cite this

@article{ece8c2f21f6c425a9777b42df58ec7fd,
title = "Peritoneal dialysis in patients with primary cardiac failure complicated by renal failure",
abstract = "Background/Aims: Clinical outcome in cardiorenal syndrome type II and treated with peritoneal dialysis (PD). Methods: Retrospective analysis over a period of 10 years. Results: Twenty-four patients with mean age at start of dialysis of 67 +/- 10 years had mean survival on dialysis of 1.03 +/- 0.84 years (median survival 1.0 year). The number of hospitalizations for cardiovascular causes were reduced (13.7 +/- 26.5 predialysis vs. 3.5 +/- 8.8 days/patient/month postdialysis, p = 0.001). Patients who survived longer than the median survival time (n = 12) also had a reduced number of hospitalizations for all causes (3.7 +/- 3.8 predialysis vs. 1.4 +/- 2.1 days/patient/month postdialysis, p = 0.041), a lower age (62 +/- 10 vs. 71 +/- 8 years, p = 0.013) and fewer had diabetes (2 vs. 7 patients, p = 0.039), but left ventricular ejection fraction was not different. Conclusion: After starting PD for cardiorenal syndrome, hospitalizations for cardiovascular causes were reduced for all patients. Survival after starting PD is highly variable. Age and diabetes seem to be significant prognostic factors, but not left ventricular ejection fraction.",
author = "T.T. Cnossen and J.P. Kooman and C.J. Konings and N.H. Lencer and K.M.L. Leunissen and {van der Sande}, F.M.",
year = "2010",
month = "1",
day = "1",
doi = "10.1159/000321102",
language = "English",
volume = "30",
pages = "146--52",
journal = "Blood Purification",
issn = "0253-5068",
publisher = "Karger",
number = "2",

}

Peritoneal dialysis in patients with primary cardiac failure complicated by renal failure. / Cnossen, T.T.; Kooman, J.P.; Konings, C.J.; Lencer, N.H.; Leunissen, K.M.L.; van der Sande, F.M.

In: Blood Purification, Vol. 30, No. 2, 01.01.2010, p. 146-52.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Peritoneal dialysis in patients with primary cardiac failure complicated by renal failure

AU - Cnossen, T.T.

AU - Kooman, J.P.

AU - Konings, C.J.

AU - Lencer, N.H.

AU - Leunissen, K.M.L.

AU - van der Sande, F.M.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Background/Aims: Clinical outcome in cardiorenal syndrome type II and treated with peritoneal dialysis (PD). Methods: Retrospective analysis over a period of 10 years. Results: Twenty-four patients with mean age at start of dialysis of 67 +/- 10 years had mean survival on dialysis of 1.03 +/- 0.84 years (median survival 1.0 year). The number of hospitalizations for cardiovascular causes were reduced (13.7 +/- 26.5 predialysis vs. 3.5 +/- 8.8 days/patient/month postdialysis, p = 0.001). Patients who survived longer than the median survival time (n = 12) also had a reduced number of hospitalizations for all causes (3.7 +/- 3.8 predialysis vs. 1.4 +/- 2.1 days/patient/month postdialysis, p = 0.041), a lower age (62 +/- 10 vs. 71 +/- 8 years, p = 0.013) and fewer had diabetes (2 vs. 7 patients, p = 0.039), but left ventricular ejection fraction was not different. Conclusion: After starting PD for cardiorenal syndrome, hospitalizations for cardiovascular causes were reduced for all patients. Survival after starting PD is highly variable. Age and diabetes seem to be significant prognostic factors, but not left ventricular ejection fraction.

AB - Background/Aims: Clinical outcome in cardiorenal syndrome type II and treated with peritoneal dialysis (PD). Methods: Retrospective analysis over a period of 10 years. Results: Twenty-four patients with mean age at start of dialysis of 67 +/- 10 years had mean survival on dialysis of 1.03 +/- 0.84 years (median survival 1.0 year). The number of hospitalizations for cardiovascular causes were reduced (13.7 +/- 26.5 predialysis vs. 3.5 +/- 8.8 days/patient/month postdialysis, p = 0.001). Patients who survived longer than the median survival time (n = 12) also had a reduced number of hospitalizations for all causes (3.7 +/- 3.8 predialysis vs. 1.4 +/- 2.1 days/patient/month postdialysis, p = 0.041), a lower age (62 +/- 10 vs. 71 +/- 8 years, p = 0.013) and fewer had diabetes (2 vs. 7 patients, p = 0.039), but left ventricular ejection fraction was not different. Conclusion: After starting PD for cardiorenal syndrome, hospitalizations for cardiovascular causes were reduced for all patients. Survival after starting PD is highly variable. Age and diabetes seem to be significant prognostic factors, but not left ventricular ejection fraction.

U2 - 10.1159/000321102

DO - 10.1159/000321102

M3 - Article

VL - 30

SP - 146

EP - 152

JO - Blood Purification

JF - Blood Purification

SN - 0253-5068

IS - 2

ER -